Form 4: Concentra Group Holdings Director Reports Share Acquisition Following Spin-Off

Director Daniel Thomas reports acquiring 53,260 shares of Concentra Group Holdings Parent, Inc. common stock as a result of the company's spin-off from Select Medical Holdings Corporation.

Summary

• Daniel Thomas, a director of Concentra Group Holdings Parent, Inc., reported acquiring 53,260 shares of common stock.
• The acquisition occurred on November 25, 2024, as a result of the distribution of Concentra shares to Select Medical Holdings Corporation shareholders.
• The shares were acquired at a price of $0, reflecting the pro-rata distribution during the spin-off.
• This transaction was voluntarily reported despite an exemption under Rule 16a-9.

Sentiment

Score: 7

Explanation: The document reflects a standard transaction following a corporate spin-off, with no negative implications. The voluntary reporting adds a positive note.

Positives

• The director's acquisition of shares indicates alignment with the company's future.
• The voluntary reporting of the transaction demonstrates transparency.

Industry Context

This transaction is a direct result of the spin-off of Concentra Group Holdings from Select Medical Holdings, a common corporate restructuring strategy.

Comparison to Industry Standards

• Spin-offs are a common corporate strategy, and the pro-rata distribution of shares to existing shareholders is a standard practice.
• The reporting of insider transactions via Form 4 is a standard regulatory requirement for publicly traded companies.

Stakeholder Impact

• The share distribution impacts shareholders of Select Medical Holdings, who now also own shares in Concentra Group Holdings.
• The transaction is not expected to have a significant impact on other stakeholders.

Key Dates

Keywords

Concentra Group Holdings, Daniel Thomas, spin-off, share acquisition, Form 4, director, Select Medical Holdings, pro-rata distribution